Si-Bone Inc (SIBN)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $1.06B
Last updated: Nov 17, 2026 at 11:05 AM ET
Si-Bone Inc (SIBN) Stock Forecast
Analysts expect Si-Bone (SIBN) to earn -$0.34 per share in the fiscal year ending Dec 31, 2026, on revenue of $232.14M. Of 9 analysts, 9 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.29.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 9 ratings average 1.67, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 3 | 33.3% |
| Buy | 6 | 66.7% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 9
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 15.5%.
- Fiscal year ending Dec 31, 2026
- -$0.34
- EPS consensus, revenue $232.14M
- Fiscal year ending Dec 31, 2027
- -$0.29
- EPS consensus, revenue $268.12M
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.34 | -$0.36 to -$0.32 | 7 | $232.14M | $231.83M to $232.90M | 9 |
| Dec 31, 2027 | -$0.29 | -$0.39 to -$0.22 | 7 | $268.12M | $265.00M to $270.13M | 9 |
Quarterly Estimates
The EPS consensus falls from -$0.07 for the quarter ending Dec 31, 2026 to -$0.10 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.07 | -$0.09 to -$0.05 | 11 | $69.24M | $66.35M to $72.03M | 11 |
| Mar 31, 2027 | -$0.10 | -$0.15 to -$0.06 | 5 | $62.38M | $60.70M to $64.04M | 6 |
Estimate Revisions
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Quarter ending Mar 31, 2027 | 2 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$0.40.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.34 | -$0.40 | -$0.40 | -$0.40 | -$0.40 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.29 | -$0.33 | -$0.33 | -$0.33 | -$0.33 | N/A |
| Quarter ending Mar 31, 2027 | -$0.10 | -$0.10 | -$0.10 | -$0.10 | -$0.10 | N/A |
Frequently Asked Questions About SIBN
What is the SIBN stock forecast?
Consensus analyst estimates put Si-Bone's EPS at -$0.34 for the fiscal year ending Dec 31, 2026, on revenue of $232.14M. The consensus rating from 9 analysts is Buy.
How do analysts rate SIBN stock?
Of 9 analysts covering Si-Bone, 3 rate it Strong Buy, 6 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from SIBN next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.34, with estimates from -$0.36 to -$0.32 from 7 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.29, with estimates from -$0.39 to -$0.22 from 7 analysts.
What revenue do analysts expect from Si-Bone next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $232.14M, with estimates from $231.83M to $232.90M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $268.12M, with estimates from $265.00M to $270.13M.
How many analysts cover SIBN?
9 analysts rate Si-Bone stock, and 7 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
SIBN pages: Overview, Earnings, Forecast, Financials, Competitors